Barton Shane
- SEC CIK
- 0001836297
In the past year, 1 open-market sale filing worth $1.58M and no purchases.
Current role at each company
- BIOA BioAge Labs, Inc.Principal Accounting Officeras of Jul 1, 2026
- DTIL Precision Biosciences IncVP & Corporate Controlleras of Jun 9, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.58M
- 1 filing
- Net
- −$1.58M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Barton Shane as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BIOA BioAge Labs, Inc.
Principal Accounting Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 (view filing)4:27 PM ET | Jun 29-30 | 2 days | Barton ShanePrincipal Accounting Officer | SSale | −62.6K | $25.20 | −$1.58M | −100.0%0 after | 2 lots10b5-1 |
| Mar 10, 2025 (view filing) | Sep 27, 2024 | 164 daysLate | Barton ShanePrincipal Accounting Officer | PPurchase | +2.63K | $18.00 | +$47.4K | New position2.63K after |